+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Promotion of ventricular tachycardia induction by procainamide in dogs with inducible ventricular fibrillation late after myocardial infarction



Promotion of ventricular tachycardia induction by procainamide in dogs with inducible ventricular fibrillation late after myocardial infarction



Pacing and Clinical Electrophysiology 13(7): 882-889



The influence of procainamide on inducible ventricular tachyarrhythmias was evaluated in 35 dogs with experimental myocardial infarction, and 9 normal dogs. Programmed stimulation was performed from the right ventricular apex via a percutaneously positioned electrode catheter, using up to five extrastimuli before and after intravenous administration of procainamide (15 mg/kg). Procainamide levels in postinfarct dogs were 8.5 +/- 0.7 micrograms/mL (range 5.3-13.6 micrograms/mL). Procainamide exerted its greatest effect in postinfarct dogs with reproducible baseline ventricular fibrillation. Six of nine dogs (P less than 0.05) with ventricular fibrillation had sustained monomorphic ventricular tachycardia (cycle length: 147 +/- 4 msec) induced after procainamide administration. This ventricular tachycardia required significantly more extrastimuli than baseline ventricular fibrillation (3 +/- 0.3 extrastimuli before vs 4 +/- 0.3 extrastimuli after procainamide). Procainamide never converted ventricular fibrillation to ventricular tachycardia in normal dogs. Procainamide had minimal effect on inducible ventricular tachycardia after myocardial infarction. Ventricular tachycardia induction was abolished in only 2 of 17 dogs despite significant prolongation of electrophysiological parameters. Ventricular tachycardia cycle length, and the number of extrastimuli required were unchanged by procainamide in this subgroup. Ventricular tachycardia is insensitive to the antiarrhythmic properties of procainamide in this model. In contrast, procainamide is able to convert postinfarction ventricular fibrillation to ventricular tachycardia, presumably by promoting sustained, organized reentry. This previously undescribed action is an unusual form of proarrhythmic effect, and suggests that this drug should be used cautiously in patients after myocardial infarction.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 041097054

Download citation: RISBibTeXText

PMID: 1695745

DOI: 10.1111/j.1540-8159.1990.tb02125.x


Related references

Electrophysiologic variables characterizing the induction of ventricular tachycardia versus ventricular fibrillation after myocardial infarction: Relation between ventricular late potentials and coupling intervals for the induction of sustained ventricular tachyarrhythmias. Journal of the American College of Cardiology 21(7): 1624-1631, 1993

Lidocaine converts inducible ventricular fibrillation into sustained ventricular tachycardia in conscious dogs with recent myocardial infarction. Cardiology 85(6): 378-387, 1994

Inducible sustained ventricular tachycardia and ventricular fibrillation in conscious dogs with isolated right ventricular infarction: relation to infarct structure. Journal of the American College of Cardiology 7(4): 850-858, 1986

Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction. Japanese Circulation Journal 52(3): 262-271, 1988

Determinants of prognosis in symptomatic ventricular tachycardia or ventricular fibrillation late after myocardial infarction. The Dutch Ventricular Tachycardia Study Group of the Interuniversity Cardiology Institute of The Netherlands. Journal of the American College of Cardiology 16(3): 521-530, 1990

Induction of ventricular fibrillation during antiarrhythmic drug treatment predicts sudden death in patients with sustained monomorphic ventricular tachycardia or ventricular fibrillation after myocardial infarction. Circulation 90(4 PART 2): I455, 1994

Ventricular late potentials and inducible ventricular tachyarrhythmias as a marker for ventricular tachycardia after myocardial infarction. European Heart Journal 7 Suppl A: 127-134, 1986

Late potentials identify patients post myocardial infarction with left ventricular dysfunction and complex ventricular ectopy who have inducible ventricular tachycardia. Circulation 78(4 PART 2): II578, 1988

Effect of procainamide on signal averaged electrocardiographic late potentials and induction of ventricular tachycardia by programmed stimulation in canine myocardial infarction. Clinical Research: 867a, 1985

Induction of ventricular fibrillation, but not of sustained monomorphic ventricular tachycardia predicts sudden death in patients on amiodarone because of ventricular tachyarrhythmias after myocardial infarction. Journal of the American College of Cardiology 0(SPEC ISSUE): 280A, 1994

Late induction of tachycardia in patients with ventricular fibrillation associated with acute myocardial infarction. Journal of the American College of Cardiology 3(3): 690-695, 1984

Effect of flecainide acetate on induced ventricular tachycardia and ventricular fibrillation in dogs with recent myocardial infarction. American Heart Association Monograph (114): III-225, 1985

Coronary venous retroinfusion of procainamide a new approach for the management of spontaneous and inducible sustained ventricular tachycardia during myocardial infarction. Journal of the American College of Cardiology 7(3): 551-563, 1986

Effect of reperfusion time on inducible ventricular tachycardia early and spontaneous ventricular arrhythmias late after ST elevation myocardial infarction treated with primary percutaneous coronary intervention. Heart Rhythm 8(4): 493-499, 2011

Association of impaired thrombolysis in myocardial infarction myocardial perfusion grade with ventricular tachycardia and ventricular fibrillation following fibrinolytic therapy for ST-segment elevation myocardial infarction. Journal of the American College of Cardiology 51(5): 546-551, 2008